Literature DB >> 12393741

Distal elements are critical for human CD34 expression in vivo.

Yutaka Okuno1, Claudia S Huettner, Hanna S Radomska, Victoria Petkova, Hiromi Iwasaki, Koichi Akashi, Daniel G Tenen.   

Abstract

The elements regulating gene expression in hematopoietic stem cells are still poorly understood. We previously reported that a 141-kilobase (kb) human CD34 transgene confers properly regulated human CD34 expression in transgenic mice. A construct with only the human CD34 promoter and 3' enhancer region is not sufficient, suggesting that critical distal elements are necessary for expression of the human CD34 gene. To further localize such elements, we analyzed deletion constructs of the human CD34 gene and evaluated their function in transgenic mice. Constructs harboring as little as 18 kb of 5' and 26 kb of 3' human CD34 flanking sequence conferred human expression in tissues of transgenic mice with a pattern similar to that of the 141-kb human transgene. In contrast, a construct harboring 10 kb of 5' and 17 kb of 3' human CD34 flanking sequence gave no expression. These data demonstrate that regions between 10 to 18 kb upstream and/or 17 to 26 kb downstream of the human CD34 gene contain critical elements for human CD34 expression in vivo. Further functional analysis of these regions in transgenic mice will be crucial for understanding CD34 gene expression in hematopoietic stem and progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393741     DOI: 10.1182/blood-2002-03-0788

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Green fluorescent protein transgene driven by Kit regulatory sequences is expressed in hematopoietic stem cells.

Authors:  Francesco Cerisoli; Letizia Cassinelli; Giuseppe Lamorte; Stefania Citterio; Francesca Bertolotti; Maria Cristina Magli; Sergio Ottolenghi
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

2.  PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.

Authors:  N Ueno; N Nishimura; S Ueno; S Endo; H Tatetsu; S Hirata; H Hata; M Matsuoka; H Mitsuya; Y Okuno
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

3.  Thrombospondin-1 deficiency causes a shift from fibroproliferative to inflammatory kidney disease and delays onset of renal failure.

Authors:  Michael Zeisberg; Björn Tampe; Valerie LeBleu; Desiree Tampe; Elisabeth M Zeisberg; Raghu Kalluri
Journal:  Am J Pathol       Date:  2014-08-10       Impact factor: 4.307

4.  Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.

Authors:  Yutaka Okuno; Gang Huang; Frank Rosenbauer; Erica K Evans; Hanna S Radomska; Hiromi Iwasaki; Koichi Akashi; Francoise Moreau-Gachelin; Youlin Li; Pu Zhang; Berthold Göttgens; Daniel G Tenen
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element.

Authors:  Elena Levantini; Sanghoon Lee; Hanna S Radomska; Christopher J Hetherington; Meritxell Alberich-Jorda; Giovanni Amabile; Pu Zhang; David A Gonzalez; Junyan Zhang; Daniela S Basseres; Nicola K Wilson; Steffen Koschmieder; Gang Huang; Dong-Er Zhang; Alexander K Ebralidze; Constanze Bonifer; Yutaka Okuno; Bertie Gottgens; Daniel G Tenen
Journal:  EMBO J       Date:  2011-08-26       Impact factor: 11.598

6.  The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

Authors:  Jun-ichi Hanai; Peirang Cao; Preeti Tanksale; Shintaro Imamura; Eriko Koshimizu; Jinghui Zhao; Shuji Kishi; Michiaki Yamashita; Paul S Phillips; Vikas P Sukhatme; Stewart H Lecker
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 7.  Biology of normal and acute myeloid leukemia stem cells.

Authors:  John E Dick; Tsvee Lapidot
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

8.  Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect.

Authors:  Peirang Cao; Jun-Ichi Hanai; Preeti Tanksale; Shintaro Imamura; Vikas P Sukhatme; Stewart H Lecker
Journal:  FASEB J       Date:  2009-04-30       Impact factor: 5.191

9.  Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1.

Authors:  Catherine M Cahill; Jack T Rogers
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

10.  PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL.

Authors:  S Ueno; H Tatetsu; H Hata; T Iino; H Niiro; K Akashi; D G Tenen; H Mitsuya; Y Okuno
Journal:  Oncogene       Date:  2009-09-14       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.